ATP Synthesis-IN-3
ATP Synthesis-IN-3 (compound 31) is an ATP hydrolysis inhibitor with protective effects during myocardial ischemia. ATP Synthesis-IN-3 can increase the ATP content of ischemic cardiomyocytes, increase the phosphorylation of PKA and phospholamban, and inhibit ischemia-induced apoptosis[1].
Product Specifications
CAS Number
[3032416-36-4]
UNSPSC
12352005
Target
ATP Synthase; PKA
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel; Stem Cell/Wnt; TGF-beta/Smad
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/atp-synthesis-in-3.html
Solubility
10 mM in DMSO
Smiles
CN1CCN(C2=CC=C(NC3=NC(N4CCOCC4)=C5C(C(C6=CC=CC=C6)=NN5CC7=CC=C(C=C7)OC)=C3)C=C2)CC1
Molecular Formula
C35H39N7O2
Molecular Weight
589.73
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items